» Articles » PMID: 16557594

Transcriptional Profiling of MCF7 Breast Cancer Cells in Response to 5-Fluorouracil: Relationship with Cell Cycle Changes and Apoptosis, and Identification of Novel Targets of P53

Overview
Journal Int J Cancer
Specialty Oncology
Date 2006 Mar 25
PMID 16557594
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The availability of oral precursors of 5-Fluorouracil (5-FU) and its favorable results in treating advanced breast cancer have renewed the interest in the molecular mechanisms underlying its cytotoxicity. We have compared the changes in cell cycle and cell death parameters induced by 2 different concentrations of 5-FU (IC50 and IC80) in the breast adenocarcinoma cell line MCF7. G1/S cell cycle arrest was associated with both concentrations, whereas cell death was mainly induced after IC80 5-FU. These changes were correlated with gene expression assessed by cDNA microarray analysis. Main findings included an overexpression of p53 target genes involved in cell cycle and apoptosis (CDKN1A/p21, TP53INP, TNFRSF6/FAS and BBC3/PUMA), and significant repression of Myc. High dose 5-FU also induced a higher regulation of the mitochondrial death genes APAF1, BAK1 and BCL2, and induction of genes of the ID family. Furthermore, we establish a direct causal relationship between p21, ID1 and ID2 overexpression, increased acetylation of histones H3 and H4 and binding of p53 to their promoters as a result of 5-FU treatment. The relevance of these findings was further studied after interfering p53 expression in MCF7 cells (shp53 cells), showing a lower induction of both, ID1 and ID2 transcripts, after 5-FU when compared with MCF7 shGFP control cells. This molecular characterization of dose- and time-dependent modifications of gene expression after 5-FU treatment should provide a resource for future basic studies addressing the molecular mechanisms of chemotherapy in breast cancer.

Citing Articles

MHESMMR: a multilevel model for predicting the regulation of miRNAs expression by small molecules.

Guan Y, Yu C, Li L, You Z, Wei M, Wang X BMC Bioinformatics. 2024; 25(1):6.

PMID: 38166644 PMC: 10763044. DOI: 10.1186/s12859-023-05629-x.


Magnetic Targeting of 5-Fluorouracil-Loaded Liposome-Nanogels for In Vivo Breast Cancer Therapy and the Cytotoxic Effects on Liver and Kidney.

Ulker D, Ozyurt R, Erkasap N, Butun V AAPS PharmSciTech. 2022; 23(8):289.

PMID: 36316521 DOI: 10.1208/s12249-022-02438-y.


Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRAS glycolytic colorectal tumors.

Ludikhuize M, Gevers S, Nguyen N, Meerlo M, Roudbari S, Gulersonmez M Commun Biol. 2022; 5(1):1159.

PMID: 36316440 PMC: 9622833. DOI: 10.1038/s42003-022-04055-8.


Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.

Leiva M, Garre E, Gustafsson A, Svanstrom A, Bogestal Y, Hakansson J J Cell Physiol. 2020; 236(6):4709-4724.

PMID: 33368325 PMC: 8049042. DOI: 10.1002/jcp.30191.


Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.

Tun J, Salvador-Reyes L, Velarde M, Saito N, Suwanborirux K, Concepcion G Mar Drugs. 2019; 17(9).

PMID: 31527453 PMC: 6780817. DOI: 10.3390/md17090536.